FINVX | PPYIX | FINVX / PPYIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 15 years | 10 years | - |
Gain YTD | 2.181 | 0.816 | 267% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 14B | 498M | 2,811% |
Annual Yield % from dividends | 3.05 | 5.59 | 55% |
Returns for 1 year | 11.28 | -0.20 | -5,666% |
Returns for 3 years | 17.70 | -7.62 | -232% |
Returns for 5 years | 47.79 | -10.24 | -467% |
Returns for 10 years | 62.02 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SEWIX | 16.07 | 0.10 | +0.63% |
NAA World Equity Income Instl | |||
PRIUX | 19.65 | 0.08 | +0.41% |
T. Rowe Price International Stock I | |||
MNDHX | 25.65 | 0.06 | +0.23% |
MFS New Discovery R3 | |||
ICELX | 38.06 | 0.03 | +0.08% |
NYLI Epoch International Choice Inv Cl | |||
FBTDX | 106.93 | -0.13 | -0.12% |
Franklin Biotechnology Discovery C |